Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration
Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Cancan Luo(Duke Medical Center), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Xiangshan Fan(Anhui Medical University), Eric D. Hsi(Mayo Clinic), Bing Xu(Fujian Medical University), Ali Sakhdari(University of Toronto), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Heounjeong Go(Ulsan College), April Chiu(Mayo Clinic), Youli Zu(Methodist Hospital), Wayne Tam(Cornell University), Qingyan Au(NeoGenomics (United States)), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Dennis P. O’Malley(Ambry Genetics (United States)), Xiaosheng Fang(Shandong Provincial Hospital), Harry Nunns(NeoGenomics (United States)), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Yu Li(North Sichuan Medical University), Mingzhi Zhang(Chinese Academy of Sciences), Yong Li(Baylor College of Medicine), Jane N. Winter(Northwestern University), Joannes H.J.M. Van Krieken(Radboud University Nijmegen), Fredrick B. Hagemeister(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k